Impact de la COVID-19 sur l'initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques.

Richette, Pascal; Allez, Matthieu; Descamps, Vincent; Perray, Lucas; Pilet, Simon; Latourte, Augustin; Maravic, Milka

Impact de la COVID-19 sur l'initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques.

Richette, Pascal; Allez, Matthieu; Descamps, Vincent; Perray, Lucas; Pilet, Simon; Latourte, Augustin; Maravic, Milka.

Richette P; Rheumatology department, Lariboisière Hospital, AP-HP, Paris, France.
Allez M; Inserm U1132, Paris University, Paris, France.
Descamps V; Gastro Enterology department, St-Louis Hospital, AP-HP, Paris, France.
Perray L; Dermatology department, Bichat Hospital, AP-HP, Paris, France.
Pilet S; IQVIA, La Défense, France.
Latourte A; IQVIA, La Défense, France.
Maravic M; Rheumatology department, Lariboisière Hospital, AP-HP, Paris, France.

Rev Rhum Ed Fr ; 89(3): 313-314, 2022 May.

Article in French | MEDLINE | ID: covidwho-1829482

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: French Journal: Rev Rhum Ed Fr Journal subject: Rheumatology Year: 2022 Document Type: Article Affiliation country: J.rhum.2021.10.560

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google